Down 50%, Is Dell Technologies a Buy?
Dell (NYSE:DELL)’s share price has been on a roller coaster…
Sell
11
VNDA Quote, Financials, Valuation and Earnings
Last price:
$4.13
Seasonality move
:
77.19%
Day range:
$4.00 - $4.30
52-week range:
$3.86 - $6.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.21x
P/B ratio:
0.45x
Volume:
882.7K
Avg. volume:
708.1K
1-year change:
-8.2%
Market cap:
$241.4M
Revenue:
$198.8M
EPS (TTM):
-$0.32
Vanda Pharmaceuticals SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
VNDA
Vanda Pharmaceuticals
|
05/09/2024 | 10-Q | 10-Q filing on 05/09/2024 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/09/2023 | 10-Q | 10-Q filing on 11/09/2023 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
07/28/2023 | 10-Q | 10-Q filing on 07/28/2023 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/03/2023 | 10-Q | 10-Q filing on 05/03/2023 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/03/2022 | 10-Q | 10-Q filing on 11/03/2022 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/04/2022 | 10-Q | 10-Q filing on 08/04/2022 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/06/2022 | 10-Q | 10-Q filing on 05/06/2022 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/04/2021 | 10-Q | 10-Q filing on 11/04/2021 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
07/29/2021 | 10-Q | 10-Q filing on 07/29/2021 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/06/2021 | 10-Q | 10-Q filing on 05/06/2021 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
10/29/2020 | 10-Q | 10-Q filing on 10/29/2020 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/06/2020 | 10-Q | 10-Q filing on 08/06/2020 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/07/2020 | 10-Q | 10-Q filing on 05/07/2020 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/26/2020 | 10-K | 10-K filing on 02/26/2020 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/07/2019 | 10-Q | 10-Q filing on 11/07/2019 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/01/2019 | 10-Q | 10-Q filing on 08/01/2019 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/03/2019 | 10-Q | 10-Q filing on 05/03/2019 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/19/2019 | 10-K | 10-K filing on 02/19/2019 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/07/2018 | 10-Q | 10-Q filing on 11/07/2018 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/02/2018 | 10-Q | 10-Q filing on 08/02/2018 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/02/2018 | 10-Q | 10-Q filing on 05/02/2018 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/15/2018 | 10-K | 10-K filing on 02/15/2018 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/08/2017 | 10-Q | 10-Q filing on 11/08/2017 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/03/2017 | 10-Q | 10-Q filing on 08/03/2017 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/03/2017 | 10-Q | 10-Q filing on 05/03/2017 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/17/2017 | 10-K | 10-K filing on 02/17/2017 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/03/2016 | 10-Q | 10-Q filing on 11/03/2016 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
07/28/2016 | 10-Q | 10-Q filing on 07/28/2016 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/05/2016 | 10-Q | 10-Q filing on 05/05/2016 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/12/2016 | 10-K | 10-K filing on 02/12/2016 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/04/2015 | 10-Q | 10-Q filing on 11/04/2015 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
07/31/2015 | 10-Q | 10-Q filing on 07/31/2015 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
06/10/2015 | 10-K | 10-K filing on 06/10/2015 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/07/2015 | 10-Q | 10-Q filing on 05/07/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How Bad Will the Stock Market Get?
In recent trading days, global stock markets have seen massive…
Is JOBY Stock a Buy, Sell or Hold?
Joby Aviation (NYSE:JOBY) got started with the big idea of…
Stock Ideas
Sell
36
Is MSFT Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 30x
Sell
30
Is AAPL Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 28x
Sell
33
Is NVDA Stock a Buy?
Market Cap: $2.3T
P/E Ratio: 33x
Alerts
Buy
55
SLNO alert for Apr 9
Soleno Therapeutics [SLNO] is up 7.3% over the past day.
Sell
20
HELE alert for Apr 9
Helen Of Troy [HELE] is up 10.1% over the past day.
Sell
18
OXM alert for Apr 9
Oxford Industries [OXM] is up 17.72% over the past day.
